Search results for " Heterozygosity"

showing 10 items of 141 documents

A bi-allelic loss-of-function SARS1 variant in children with neurodevelopmental delay, deafness, cardiomyopathy, and decompensation during fever

2021

Aminoacyl-tRNA synthetases (aaRS) are ubiquitously expressed enzymes responsible for ligating amino acids to their cognate tRNA molecules through an aminoacylation reaction. The resulting aminoacyl-tRNA is delivered to ribosome elongation factors to participate in protein synthesis. Seryl-tRNA synthetase (SARS1) is one of the cytosolic aaRSs and catalyzes serine attachment to tRNASer . SARS1 deficiency has already been associated with moderate intellectual disability, ataxia, muscle weakness, and seizure in one family. We describe here a new clinical presentation including developmental delay, central deafness, cardiomyopathy, and metabolic decompensation during fever leading to death, in a…

AtaxiabrainCardiomyopathySARS1Loss of HeterozygosityBiologyAmino Acyl-tRNA Synthetaseschemistry.chemical_compounddeafnessdeathGeneticsmedicineProtein biosynthesisMissense mutationHumansDecompensationaminoacyl-tRNA synthetaseChildtRNAGenetics (clinical)GeneticsaminoacylationAminoacyl tRNA synthetasemedicine.diseaseElongation factorchemistryintellectual disabilityTransfer RNAmedicine.symptomCardiomyopathiesHuman mutation
researchProduct

Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.

1998

Protein expression of the putative tumour-suppressor gene DCC on chromosome 18q was evaluated in a panel of 16 matched colorectal cancer and normal colonic tissue samples together with DCC mRNA expression and allelic deletions (loss of heterozygosity, LOH). Determined by a polymerase chain reaction (PCR)-LOH assay, 12 of the 16 (75%) cases were informative with LOH occurring in 2 of the 12 cases. For DCC mRNA, transcripts could be detected in all analysed normal tissues (eight out of eight) by RT-PCR, whereas 6 of the 15 tumours were negative. DCC protein expression, investigated by immunohistochemistry using the monoclonal antibody 15041 A directed against the intracellular domain, was hom…

Cancer ResearchDeleted in Colorectal CancerDNA Mutational AnalysisLoss of HeterozygosityReceptors Cell SurfaceBiologymedicine.disease_causePolymerase Chain ReactionLoss of heterozygosityGene productmedicineHumansGenes Tumor SuppressorRNA MessengerRNA NeoplasmCodonGeneMessenger RNAMutationTumor Suppressor ProteinsfungiDCC ReceptorImmunohistochemistryNeoplasm ProteinsBlotting SouthernOncologyCancer researchImmunohistochemistryColorectal NeoplasmsCell Adhesion MoleculesImmunostainingResearch ArticleBritish Journal of Cancer
researchProduct

Allelic loss but absence of mutations in the polyspecific transporter geneBWR1Aon 11p15.5 in hepatoblastoma

2004

Chromosomal region 11p15.5 shows frequent maternal allelic loss in embryonal tumors, including rhabdomyosarcoma (RMS), Wilms' tumor (WT) and hepatoblastoma (HB), consistent with the presence of at least one tumor suppressor gene in this region, which should be paternally imprinted, i.e., expressed from the maternal allele only. The BWR1A gene encodes a polyspecific transmembrane transporter and is located on 11p15.5. It is highly expressed in liver, paternally imprinted and was found to be mutated in an RMS cell line, making it a plausible tumor suppressor gene for HB. We therefore screened 62 HBs, 3 HB cell lines and 1 pediatric hepatocellular carcinoma for BWR1A mutations using single-str…

Cancer ResearchHepatoblastomaTumor suppressor geneBiologymedicine.diseaseMolecular biologyLoss of heterozygosityExonOncologyGene expressionChromosomal regionmedicineRhabdomyosarcomaGeneInternational Journal of Cancer
researchProduct

Pattern of secondary genomic changes in pancreatic tumors ofTgfα/Trp53+/−transgenic mice

2003

Trp53+/− mice overexpressing Tgfα in a pancreas-specific manner represent a well-established animal model for pancreatic cancer. In this study we analyzed 38 pancreatic adenocarcinomas of these mice for secondary genomic changes by comparative genomic hybridization (CGH), loss of heterozygosity (LOH) analysis, real-time PCR, and methylation-specific analysis. CGH screening of the tumors revealed a recurrent pattern of genomic changes. In more than 50% of the tumors, chromosome 11 was affected. The gain of the proximal part spans about 16 cM, including the genes for Egfr, Rel, and Stk10. The distal part of chromosome 11, which contains the Trp53 locus, was deleted. LOH analysis proved that a…

Cancer ResearchLocus (genetics)Biologymedicine.diseaseMolecular biologyLoss of heterozygosityChromosome 15Chromosome 4CDKN2APancreatic cancerDNA methylationGeneticsmedicineComparative genomic hybridizationGenes, Chromosomes and Cancer
researchProduct

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.

2004

HLA class I loss or downregulation is a widespread mechanism used by tumor cells to avoid tumor recognition by cytotoxic T lymphocytes favoring tumor immune escape. Multiple molecular mechanisms are responsible for these altered HLA class I tumor phenotypes. It has been described in different epithelial tumors that loss of heterozygosity (LOH) at chromosome region 6p21.3 is a frequent mechanism that leads to HLA haplotype loss, ranging between 40 and 50%, depending on the tumor entity analyzed. Here we have tested the frequency of LOH at 6p21 chromosome region in Renal Cell Carcinomas (RCC) of the clear cell and chromophobe subtype. A low frequency of HLA haplotype loss (6.6%) was found in …

Cancer ResearchPathologymedicine.medical_specialtyLoss of HeterozygosityChromophobe cellHuman leukocyte antigenBiologyurologic and male genital diseasesLoss of heterozygosityAntigens NeoplasmHLA AntigensmedicineCytotoxic T cellHumansneoplasmsCarcinoma Renal CellHaplotypeCytogeneticsKidney NeoplasmsGene Expression Regulation NeoplasticOncologyHaplotypesClear cell carcinomaChromosomes Human Pair 6Clear cellAdenocarcinoma Clear CellMicrosatellite RepeatsInternational journal of cancer
researchProduct

Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification

1993

Renal-cell carcinomas (RCC) are clinically, histologically and cytogenetically very heterogeneous. The present histological WHO classification shows no clear correlation between histologic subtypes and specific chromosomal abnormalities. In 1986, a new classification was proposed by Thoenes and Storkel based on the cell type from which the tumor arises. They distinguish S cell types: clear-cell, chromophilic, chromophobic, ductus Bellini and oncocytic. Results of 105 primary tumors show that, in this new classification, there is a correlation between different subtypes of renal-cell tumor and specific chromosomal abnormalities at a microscopic and/or molecular level. The clear-cell compact …

Cancer ResearchPathologymedicine.medical_specialtyMonosomyCell typeCARCINOMAChromosome DisordersHistogenesisBiologyPolysomy 7Loss of heterozygositymedicineHumansCarcinoma Renal CellChromosome AberrationsChromosome 7 (human)PolysomyPloidiesABNORMALITIESCytogeneticsDNA Neoplasmmedicine.diseaseKidney NeoplasmsONCOCYTOMASOncologyTISSUEKaryotypingInternational Journal of Cancer
researchProduct

Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection

2021

Background: Hepatic resection remains the treatment of choice for patients with early-stage HCC with preserved liver function. Unfortunately, however, the majority of patients develop tumor recurrence. While several clinical factors were found to be associated with tumor recurrence, HCC pathogenesis is a complex process of accumulation of somatic genomic alterations, which leads to a huge molecular heterogeneity that has not been completely understood. The aim of this study is to complement potentially predictive clinical and pathological factors with next-generation sequencing genomic profiling and loss of heterozygosity analysis. Methods: 124 HCC patients, who underwent a primary hepatic …

Cancer Researchmedicine.medical_specialtyHepatitis C virusSubgroup analysisLower riskmedicine.disease_causelcsh:RC254-282GastroenterologyArticlePathogenesisLoss of heterozygositynext-generation sequencing.03 medical and health sciences0302 clinical medicineInternal medicineMedicinePTENHCCHCC recurrencebiologybusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOncology030220 oncology & carcinogenesisHepatocellular carcinomaliver resectionbiology.proteinnext-generation sequencingloss of heterozygosity030211 gastroenterology & hepatologyLiver functionbusinessCancers
researchProduct

Insights into Genetic Diversity, Runs of Homozygosity and Heterozygosity-Rich Regions in Maremmana Semi-Feral Cattle Using Pedigree and Genomic Data

2020

Semi-feral local livestock populations, like Maremmana cattle, are the object of renewed interest for the conservation of biological diversity and the preservation and exploitation of unique and potentially relevant genetic material. The aim of this study was to estimate genetic diversity parameters in semi-feral Maremmana cattle using both pedigree- and genomic-based approaches (FIS and FROH), and to detect regions of homozygosity (ROH) and heterozygosity (ROHet) in the genome. The average heterozygosity estimates were in the range reported for other cattle breeds (HE=0.261, HO=0.274). Pedigree-based average inbreeding (F) was estimated at 4.9%. The correlation was low between F and genomi…

Candidate geneMaremmanaGenomic relationshipinbreedingheterozygosity-rich regionspedigree relationshipsBiologyRuns of Homozygositymaremmana cattleGenomeArticlesemi-feral cattleLoss of heterozygositySettore AGR/17 - Zootecnica Generale E Miglioramento Geneticomaremmana cattle; runs of homozygosity; inbreeding; heterozygosity-rich regions; pedigree relationships; genomic relationshipslcsh:ZoologyGenomic relationships; Heterozygosity-rich regions; Inbreeding; Maremmana cattle; Pedigree relationships; Runs of homozygositylcsh:QL1-991genomic relationshipsruns of homozygosityGenetic diversitylcsh:Veterinary medicineGeneral Veterinarybusiness.industrygenetic diversitybiology.organism_classificationROH islandsTheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESEvolutionary biologylcsh:SF600-1100Pedigree relationshipAnimal Science and ZoologyLivestockbusinessHeterozygosity-rich regionInbreedinglinkage disequilibriumeffective population sizeAnimals
researchProduct

GIST: Particular aspects related to cell cultures, xenografts, and cytogenetics

2006

In less than half a decade, gastrointestinal stromal tumors (GIST) have emerged from historical anonymity to become a model of kinase-targeted therapies. Approximately 80% to 85% of GISTs harbor activating mutations of the KIT or PDGFRA tyrosine kinase genes, and such mutations have predictive and prognostic value. In this regard, the in vitro and in vivo models have provided valuable tools for understanding the molecular pathology of this interesting neoplasm. This review charts particular aspects in the field of cell cultures and tumor xenografts in nude mice in GIST and their implication in the establishment of appropriate models for discovering and testing therapy. The cytogenetic featu…

Candidate genemedicine.medical_specialtyPathologyGastrointestinal Stromal TumorsTransplantation HeterologousCell Culture TechniquesMice NudePDGFRABiologyBioinformaticsModels BiologicalPathology and Forensic MedicineLoss of heterozygosityCytogeneticsMicemedicineAnimalsHumansneoplasmsOligonucleotide Array Sequence AnalysisGiSTMolecular pathologyCytogeneticsNucleic Acid HybridizationPrognosisdigestive system diseasesTransplantationComparative genomic hybridizationSeminars in Diagnostic Pathology
researchProduct

Eight million years of maintained heterozygosity in chromosome homologs of cercopithecine monkeys

2020

In the Cercopithecini ancestor two chromosomes, homologous to human chromosomes 20 and 21, fused to form the Cercopithecini specific 20/21 association. In some individuals from the genus Cercopithecus, this association was shown to be polymorphic for the position of the centromere, suggesting centromere repositioning events. We set out to test this hypothesis by defining the evolutionary history of the 20/21 association in four Cercopithecini species from three different genera. The marker order of the various 20/21 associations was established using molecular cytogenetic techniques, including an array of more than 100 BACs. We discovered that five different forms of the 20/21 association w…

Chromosomes Artificial BacterialHeterozygoteOld WorldCentromereSettore BIO/08 - AntropologiaGenomeChromosome PaintingEvolution MolecularLoss of heterozygosity03 medical and health sciences0302 clinical medicineChromosome DuplicationCentromereGeneticsHomologous chromosomeAnimalsHumansIn Situ Hybridization FluorescenceGenetics (clinical)030304 developmental biology0303 health sciencesChromosomes Heterozygosity Primates Evolution Heterozygous advantageCercopitheciniPhylogenetic treebiologyChromosomeHaplorhinibiology.organism_classificationBiological EvolutionChromosomes MammalianEvolutionary biologyKaryotyping030217 neurology & neurosurgery
researchProduct